£55.00

LAP Lambert Academic Publishing Silymarin protection role in modulating ribavirin genotoxicity: Evaluation of the antioxidant silymarin role in modulating the in vivo genotoxicity of the antiviral drug ribavirin

Price data last checked 56 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£55 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days • 35 data points (No recent data available)

Historical
Generating forecast...
£55.00 £52.25 £53.35 £54.45 £55.55 £56.65 £57.75 11 March 2026 19 March 2026 28 March 2026 05 April 2026 14 April 2026

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price
35 days 0 9 18 26 35 £55 Days at Price

Price Analysis

Most common price: £55 (35 days, 100.0%)

Price range: £55 - £55

Price levels: 1 different prices over 35 days

Description

Hepatitis C virus (HCV), first described in 1989, is now recognized as one of the main causes of chronic liver disease worldwide. HCV infection becomes chronic in the majority of cases. All current treatment protocols for hepatitis C are based on the use of interferon alpha and ribavirin (RBV). Despite RBV broad spectrum in treatment of various viral infections, recently several reports revealed genotoxic effects of RBV in vivo and in vitro. This genotoxicity was correlated with the production of reactive oxygen species (ROS). This study aimed to evaluate RBV genotoxicity and investigate the role of the natural antioxidant silymarin (SL) to modulate RBV genotoxicity. In the present study, RBV was injected i.p. at three dose levels either as a single injection or multiple injections for 5 consecutive days. Other groups were treated with SL (70 mg/kg)1hr before RBV injection. Mice were sacrificed at different sampling time after RBV treatment. Micronucleus (MN) and SSCP assays were used as cytogenetic assay and molecular end point to assess genotoxic and cytotoxic effects of RBV and to evaluate SL pretreatment protection effect. About the Author Dr. Nahed Ahmed Hussien working as a Lecturer (form 2010 up to now) at Cairo University, Science Faculty, Zoology Department specified in Molecular Biology, Genetics and Histology branches. Contributed at the Egyptian Reference Diagnostic Center in Fasciola Vaccine projects, and also in Welcome Trust HCV Projects.Married with one daughter (AISHA).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
12 May 2012
Listed Since
16 May 2012

Barcode

No barcode data available

Similar Products You Might Like

Hepatitis C: State of the Art at the Millennium: A Bound Compilation of Issues 1 and 2 of Seminars in Liver Disease (2000)
96% match

Hepatitis C: State of the Art at the Millennium: A Bound Compilation of Issues 1 and 2 of Seminars in Liver Disease (2000)

Thieme

£76.93 15 Apr 2026
Antiviral Methods and Protocols: 1030 (Methods in Molecular Biology, 1030)
96% match

Antiviral Methods and Protocols: 1030 (Methods in Molecular Biology, 1030)

Humana

£85.59 09 Mar 2026
The Molecular Medicine of Viral Hepatitis (Molecular Medical Science Series)
96% match

The Molecular Medicine of Viral Hepatitis (Molecular Medical Science Series)

Wiley-Blackwell

£75.00 28 Feb 2026
Protocols in In Vitro Hepatocyte Research: 1250 (Methods in Molecular Biology, 1250)
96% match

Protocols in In Vitro Hepatocyte Research: 1250 (Methods in Molecular Biology, 1250)

Humana

£80.69 09 Apr 2026
Hepatitis C: Antiviral Drug Discovery and Development
96% match

Hepatitis C: Antiviral Drug Discovery and Development

Caister Academic Press Limited

£218.97 24 Jan 2026
Hepatitis C Virus Disease: Immunobiology and Clinical Applications
96% match

Hepatitis C Virus Disease: Immunobiology and Clinical Applications

Springer

£107.32 12 Dec 2025
Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America (Volume 32-2) (The Clinics: Internal Medicine, Volume 32-2)
96% match

Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America (Volume 32-2) (The Clinics: Internal Medicine, Volume 32-2)

Elsevier

£73.86 09 Mar 2026
Hepatitis B Virus in Human Diseases (Molecular and Translational Medicine)
96% match

Hepatitis B Virus in Human Diseases (Molecular and Translational Medicine)

Humana

£67.31 08 Mar 2026
Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)
96% match

Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)

Humana

£102.16 18 Apr 2026
Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future
96% match

Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future

Springer

£100.10 08 Feb 2026
Hepatitis C Virus Treatment: Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance
96% match

Hepatitis C Virus Treatment: Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance

Springer

£72.56 10 Mar 2026
Chronische Virushepatitis und ihre Behandlung mit Interferon alfa
96% match

Chronische Virushepatitis und ihre Behandlung mit Interferon alfa

Springer

£43.09 18 Apr 2026
Robbins & Cotran Pathologic Basis of Disease (Robbins Pathology)
96% match

Robbins & Cotran Pathologic Basis of Disease (Robbins Pathology)

Elsevier

£84.00 25 Jan 2026
HCV: The Journey from Discovery to a Cure: Volume I: 31 (Topics in Medicinal Chemistry, 31)
96% match

HCV: The Journey from Discovery to a Cure: Volume I: 31 (Topics in Medicinal Chemistry, 31)

Springer

£250.00 30 Jan 2026
HCV: The Journey from Discovery to a Cure: Volume I: 31 (Topics in Medicinal Chemistry, 31)
96% match

HCV: The Journey from Discovery to a Cure: Volume I: 31 (Topics in Medicinal Chemistry, 31)

£261.47 07 Jan 2026
HCV: The Journey from Discovery to a Cure: Volume II: 32 (Topics in Medicinal Chemistry, 32)
96% match

HCV: The Journey from Discovery to a Cure: Volume II: 32 (Topics in Medicinal Chemistry, 32)

Springer

£232.00 16 Dec 2025
Hepatitis B Virus: Methods and Protocols: 1540 (Methods in Molecular Biology, 1540)
96% match

Hepatitis B Virus: Methods and Protocols: 1540 (Methods in Molecular Biology, 1540)

Humana

£80.09 09 Mar 2026
Prevention of Progression in Chronic Liver Disease: An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Popper's 100th birthday: 138A (Falk Symposium, 138A)
96% match

Prevention of Progression in Chronic Liver Disease: An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Popper's 100th birthday: 138A (Falk Symposium, 138A)

Springer

£77.88 19 Apr 2026
Infections of the Liver and Biliary System, An Issue of Gastroenterology Clinics of North America: Volume 49-2 (The Clinics: Internal Medicine, Volume 49-2)
95% match

Infections of the Liver and Biliary System, An Issue of Gastroenterology Clinics of North America: Volume 49-2 (The Clinics: Internal Medicine, Volume 49-2)

Elsevier

£64.63 08 Mar 2026
Die immunsuppressive Therapie der chronisch-aktiven Hepatitis
95% match

Die immunsuppressive Therapie der chronisch-aktiven Hepatitis

Springer

£46.99 19 Apr 2026
Hepatitis C Virus II: Infection and Disease: 2
95% match

Hepatitis C Virus II: Infection and Disease: 2

Springer

£128.12 28 Feb 2026
Hepatitis C Virus II: Infection and Disease: 2
95% match

Hepatitis C Virus II: Infection and Disease: 2

Springer

£128.34 02 Feb 2026
Chronic Viral Hepatitis: Management and Control
95% match

Chronic Viral Hepatitis: Management and Control

Foster Academics

£72.50 04 Mar 2026
Cellular Injury in Liver Diseases (Cell Death in Biology and Diseases)
95% match

Cellular Injury in Liver Diseases (Cell Death in Biology and Diseases)

Springer

£111.67 01 Feb 2026